Back to Journals » Neurobehavioral HIV Medicine » Volume 4

Substance abuse, hepatitis C, and aging in HIV: common cofactors that contribute to neurobehavioral disturbances

Authors Schuster, Gonzalez R

Received 25 August 2011

Accepted for publication 20 September 2011

Published 15 February 2012 Volume 2012:4 Pages 15—34

DOI https://doi.org/10.2147/NBHIV.S17408

Review by Single-blind

Peer reviewer comments 2

Randi Melissa Schuster1, Raul Gonzalez2

1Department of Psychology, University of Illinois at Chicago, Chicago, IL, USA; 2Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA

Abstract: Although the prevalence of neurocognitive disturbances among individuals with HIV has decreased in recent years, rates of impairment still remain high. This review presents findings on comorbid conditions that may contribute to further neurocognitive impairments in this already vulnerable population. The authors will focus on three cofactors that have received substantial attention in the neuroAIDS literature: drug use, hepatitis C virus (HCV) coinfection, and aging. All three conditions commonly co-occur with HIV and likely interact with HIV in complex ways. Collectively, the extant literature suggests that drug use, HCV, and aging serve to worsen the neurocognitive profile of HIV through several overlapping mechanisms. A better understanding of how specific comorbidities interact with HIV may reveal specific phenotypes of HIV-associated neurocognitive disorder that may aid in the development of more effective behavioral and pharmacological treatment efforts.

Keywords: drug use, neurocognition, HIV cofactors; HIV-associated neurocognitive disorder (HAND)

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]